Balaxi Pharmaceuticals Limited
NSE:BALAXI.NS
86.04 (INR) • At close November 8, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) INR.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets: | ||||||||||||
Current Assets: | ||||||||||||
Cash & Cash Equivalents
| 622.906 | 282.168 | 71.929 | 16.69 | 40.007 | 1.33 | 16.46 | 23.038 | 0.001 | 0.002 | 5.468 | 5.309 |
Short Term Investments
| 2.812 | 2,441.389 | 1.843 | 0 | 0 | 0 | 0 | -0.012 | 0.001 | 0 | 0.148 | 0.025 |
Cash and Short Term Investments
| 622.906 | 282.168 | 71.929 | 16.69 | 40.007 | 1.33 | 16.46 | 23.038 | 0.002 | 0.002 | 5.616 | 5.334 |
Net Receivables
| 557.051 | 550.73 | 350.789 | 784.305 | 299.094 | 56.436 | 0 | 0 | 0.02 | 0.07 | 2.886 | 0.347 |
Inventory
| 821.68 | 1,050.233 | 987.036 | 136.179 | 8.321 | -56.436 | 0 | 0 | 0 | -0.049 | 0 | 0 |
Other Current Assets
| -2,001.637 | 51.978 | 0.277 | 0.533 | 1.191 | 56.436 | 16.867 | 2.342 | 0.003 | 0.003 | 1.751 | 2.004 |
Total Current Assets
| 2,101.718 | 1,935.109 | 1,410.031 | 937.707 | 348.613 | 57.766 | 16.46 | 25.38 | 0.026 | 0.026 | 10.254 | 7.685 |
Non-Current Assets: | ||||||||||||
Property, Plant & Equipment, Net
| 147.783 | 190.155 | 52.024 | 11.686 | 1.866 | 0.114 | 0.094 | 0.021 | 0 | 0 | 0.008 | 0.012 |
Goodwill
| 261.004 | 252.235 | 233.02 | 12.791 | 0 | 0 | 0 | 0.358 | -0.009 | 0 | 0 | 0 |
Intangible Assets
| 7.78 | 9.095 | 8.247 | 8.247 | 0 | 0 | 0 | -0.355 | 0.009 | 0 | 0 | 0 |
Goodwill and Intangible Assets
| 261.004 | 252.235 | 241.267 | 12.791 | 0 | 0 | -16.877 | 0.003 | -0 | -0 | 0 | 0 |
Long Term Investments
| -2,583.432 | -2,396.69 | 44.699 | 34.164 | 0 | 0 | 0.011 | 0.015 | 32.59 | 34.133 | 1.778 | 4.685 |
Tax Assets
| 2,583.432 | 2,396.69 | -44.699 | -34.164 | 359.709 | 61.078 | 16.867 | 0.358 | 0.004 | -0 | 0 | 0 |
Other Non-Current Assets
| 72.927 | 19.191 | 61.384 | 34.625 | -350.477 | -57.88 | 0.312 | -0.012 | -32.263 | -33.791 | 0 | -4.697 |
Total Non-Current Assets
| 481.714 | 461.581 | 354.675 | 59.102 | 11.098 | 3.312 | 0.406 | 0.385 | 0.331 | 0.342 | 1.786 | 4.697 |
Total Assets
| 2,583.432 | 2,396.69 | 1,764.706 | 996.796 | 359.711 | 61.078 | 16.867 | 25.766 | 0.357 | 0.368 | 12.04 | 12.382 |
Liabilities & Equity: | ||||||||||||
Current Liabilities: | ||||||||||||
Account Payables
| 290.384 | 364.803 | 491.145 | 220.578 | 48.467 | 20.801 | 0.944 | 0.003 | 0 | 0.013 | 0 | 0 |
Short Term Debt
| 176.61 | 107.51 | 36.381 | 36.592 | 0 | 0 | 0 | -0.005 | 0.02 | 0.025 | 1.848 | 1.636 |
Tax Payables
| 0 | 50.566 | 50.566 | 24.624 | 24.624 | 4.702 | 0.069 | 0 | 0 | 0 | 0 | 0 |
Deferred Revenue
| 28.833 | 50.566 | 0 | 88.474 | 0 | 0 | 0 | 1.837 | 0 | -0.025 | 0 | 0 |
Other Current Liabilities
| 46.153 | 8.454 | 105.15 | 1.283 | 33.751 | 5.072 | 0.377 | 0.339 | 0.022 | 0.033 | 2.395 | 3.225 |
Total Current Liabilities
| 541.98 | 531.333 | 632.676 | 346.927 | 82.218 | 25.873 | 1.321 | 2.174 | 0.042 | 0.046 | 4.242 | 4.861 |
Non-Current Liabilities: | ||||||||||||
Long Term Debt
| 17.432 | 25.555 | 25.555 | 443.813 | -82.252 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Revenue Non-Current
| -28.4 | 567.892 | -25.555 | 346.998 | 82.252 | 25.873 | 1.321 | 0.456 | 0 | 0 | 0 | 0 |
Deferred Tax Liabilities Non-Current
| 9.954 | 11.005 | 0.388 | 0.071 | 0.034 | 0 | 0 | 0 | 0.001 | 0 | 0 | 0 |
Other Non-Current Liabilities
| 28.833 | -567.893 | 0.001 | -790.811 | -0.001 | -25.873 | -1.321 | -0.456 | 0.019 | 0 | 0 | 0 |
Total Non-Current Liabilities
| 27.819 | 36.559 | 0.389 | 0.071 | 0.033 | 0 | -15.14 | -0 | 0.02 | 0 | 0 | 0 |
Total Liabilities
| 569.799 | 567.892 | 633.065 | 346.998 | 82.251 | 25.873 | 1.321 | 2.174 | 0.042 | 0.046 | 4.242 | 4.861 |
Equity: | ||||||||||||
Preferred Stock
| 0 | 1,431.094 | 918.651 | 436.807 | 64.466 | 3.175 | 0 | 0 | 0 | 0 | 0 | 7.27 |
Common Stock
| 108.977 | 101.813 | 100 | 100 | 100 | 30.4 | 30.4 | 30.4 | 0.304 | 0.304 | 7 | 7 |
Retained Earnings
| 2,013.633 | 1,431.094 | 918.65 | 436.807 | 64.469 | 3.175 | -16.485 | -8.439 | -0.005 | 0.002 | 0.546 | 0.27 |
Accumulated Other Comprehensive Income/Loss
| 2,013.633 | 103.43 | 0.461 | 0.461 | 0.461 | 0.461 | 15.546 | 23.245 | 0.461 | 0.25 | 0.25 | 0.25 |
Other Total Stockholders Equity
| -2,122.61 | -1,238.633 | -806.121 | -324.277 | 48.064 | -2.005 | 2.569 | -12.829 | -0.444 | -0.234 | 0 | -14.54 |
Total Shareholders Equity
| 2,013.633 | 1,828.798 | 1,131.641 | 649.798 | 277.46 | 35.205 | 15.546 | 23.592 | 0.315 | 0.322 | 7.796 | 7.52 |
Total Equity
| 1,567.337 | 1,679.695 | 1,096.093 | 669.7 | 237.453 | 33.876 | -0.914 | 0.231 | 0.315 | 0.322 | 7.796 | 7.52 |
Total Liabilities & Shareholders Equity
| 2,583.432 | 2,396.69 | 1,764.706 | 996.796 | 359.711 | 61.078 | 16.867 | 25.766 | 0.357 | 0.368 | 12.039 | 12.381 |